The Characteristics of Antioxidant Activity after Liver Transplantation in Biliary Atresia Patients
Table 1
Descriptive data of the children.
Groups
Normal
BA
LT
Hepatitis
()
()
()
()
Age (yr) (mean ± standard error [SE])
2.1 ± 1.5
1.9 ± 0.8
8.6 ± 0.9
2.4 ± 1.2
Sex (male/female)
1.1 : 1
1.1 : 1
0.8 : 1
0.8 : 1
Physical signs, number (%)
Jaundice
0 (0)
26 (100)
0 (0)
6 (100)
Edema of the lower limbs
0 (0)
0 (0)
0 (0)
0 (0)
Hepatomegaly
0 (0)
8 (30.7)
3 (11.5)
2 (33.3)
Splenomegaly
0 (0)
11 (42.3)
3 (11.5)
1 (16.7)
Ascites
0 (0)
2 (7.6)
0 (0)
0 (0)
Liver function tests (mean ± SE)
bil(D) (mg/dL)
0.2 ± 0.1
4.4 ± 0.8
0.3 ± 0.1
3.4 ± 0.9
bil(T) (mg/dL)
0.50 ± 0.2
6.5 ± 1.2
0.8 ± 0.1
5.1 ± 1.3
AST (U/L)
35.8 ± 3.8
163.4 ± 30.5
32.7 ± 5.7
341.9 ± 177.3
ALT (U/L)
21.4 ± 5.6
121.8 ± 26.4
36.5 ± 6.4
184.0 ± 110.9
ALP (U/L)
150.3 ± 15.4
510.0 ± 81.3
288.5 ± 25.8
314.0 ± 152.0
Albumin (g [%])
4.1 ± 0.2
3.0 ± 0.6
4.0 ± 0.4
3.1 ± 0.8
BA: biliary atresia before liver transplantation; LT: biliary atresia after liver transplantation; bil(D): direct bilirubin; bil(T): total bilirubin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase. All results represent means ± standard error (SE). versus normal; versus BA.
